OncoCyte
OCX
$2.93
Share price
-3.93%
Change (1 day)
1,173.91%
Change (1 year)
Categories
OncoCyte (OCX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $54.42 M
According to OncoCyte 's latest financial reports the company's total liabilities are $54.42 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
OncoCyte - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $65.79 M | -30.26% |
| 2021-12-31 | $94.34 M | 330.1% |
| 2020-12-31 | $21.93 M | 143.17% |
| 2019-12-31 | $9.02 M | 48.01% |
| 2018-12-31 | $6.09 M | 4.85% |
| 2017-12-31 | $5.81 M | 26.78% |
| 2016-12-31 | $4.58 M | 98.14% |
| 2015-12-31 | $2.31 M | -63.36% |
| 2014-12-31 | $6.31 M | 35.17% |
| 2013-12-31 | $4.67 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -48.70% | 🇺🇸 USA |